Compounding Pharmacy · Houston, TX · 503A
Optimal Balance Pharmacy Review
Optimal Balance Pharmacy (operating as OBPRX) is a 503A sterile compounding pharmacy at 2204 Cypress Creek Pkwy Ste F&G, Houston, TX 77090. NPI 1306535307. Owner Christopher Quintana. Inspected by the Texas State Board of Pharmacy and via the NABP Verified Pharmacy Program (VPP); USP <795>/<797>/<800> compliant; PCCA member for API sourcing. The pharmacy lists GLP-1 compounding among its sterile-lab specialties but does not publicly enumerate specific products on its public website as of May 2026. Its licensure page lists 31 states plus DC as licensed, with 18 more states marked license pending.
OBPRX's credentials rest on inspections by the Texas board and NABP's Verified Pharmacy Program rather than PCAB accreditation, a distinction our look at PCAB's role helps explain. With 31 states plus DC licensed and 18 more marked pending, check its licensure page and how your state treats compounded GLP-1s before a prescription is sent.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Top-Rated GLP-1 Partners
Not sourced from Optimal Balance Pharmacy — these are our highest-scored vetted GLP-1 telehealth partners, if you'd rather start with a provider we've walked through end to end.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
No insurance needed · HSA/FSA eligible · vetted by our editors
Ro
FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Starting price: $149/mo (+ required membership)
Get started →Read review Ro →Collective
The lowest flat medication price if you can absorb an annual membership fee
Starting price: $59/mo (+ required membership)
Get started →Read review Collective →CoreAge Rx
Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Starting price: $79/mo (starting price)
Get started →Read review CoreAge Rx →Embody
Low flat-rate compounded GLP-1 pricing at every dose
Starting price: $79/mo (sale price)
Get started →Read review Embody →| Provider | Starting price | |
|---|---|---|
7.7Ro | $149/mo (+ required membership) | Get started → |
8.3Collective | $59/mo (+ required membership) | Get started → |
8.3CoreAge Rx | $79/mo (starting price) | Get started → |
7.8Embody | $79/mo (sale price) | Get started → |
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (32)
Regulatory Actions
What Our Score Weighs
- Accreditation
- No PCAB accreditation on record
- Regulatory record
- No public actions on record
- State licensure
- 32 states
- GLP-1 compounding
- Semaglutide and tirzepatide
- Track record
- Founding year not published
The 5.5/10 above is our editorial judgment across these five factors, including how serious any regulatory action was. It is not an average of them. See our methodology for details.
Medium confidence · Pharmacy details last verified November 2026 · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology (as of November 2026)
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.